Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Chair in Gene Therapy



+44 (0)20 7594 7937e.alton




Miss Samia Soussi +44 (0)20 7594 7980




Emmanuel Kaye BuildingRoyal Brompton Campus





Eric Alton is Professor of Gene Therapy and Respiratory Medicine, National Heart & Lung Institute, Imperial College London and Honorary Consultant Physician, Royal Brompton Hospital

Professor Alton was educated at Jesus College, Cambridge and Westminster Medical School and subsequently undertook six years of general medical training.  Over the last fifteen years, he has been involved in developing gene therapy for cystic fibrosis and angiogenesis, including three clinical trials.

Professor Alton coordinates the UK CF Gene Therapy Consortium which brings together the three centres in the UK (Edinburgh and Oxford Universities and Imperial College), including approximately 80 clinicians and scientists focused on this problem.




Alton EWFW, Boyd AC, Davies JC, et al., 2020, Gene Therapy for Respiratory Diseases: Progress and a Changing Context, Human Gene Therapy, Vol:31, ISSN:1043-0342, Pages:911-916

Morris-Rosendahl DJ, Edwards M, McDonnell MJ, et al., 2020, Whole-gene sequencing of CFTR reveals a high prevalence of the intronic variant c.3874-4522A>G in cystic fibrosis., American Journal of Respiratory and Critical Care Medicine, Vol:201, ISSN:1073-449X, Pages:1438-1441

Bayfield KJ, Alton E, Irving S, et al., 2020, “Nitrogen offset in N2 multiple washout method”. Katie J. Bayfield, Eric Alton, Samantha Irving, Andrew Bush, Jane C. Davies. ERJ Open Res 2019; 6: 00043-2020, Erj Open Research, Vol:6, ISSN:2312-0541, Pages:1-1

Davies J, Bayfield K, Alton E, et al., 2020, Letter to the ERJ OPEN reply 24th January 2020

Bayfield KJ, Alton E, Irving S, et al., 2020, Nitrogen offset in N-2 multiple washout method, Erj Open Research, Vol:6

More Publications